SCHEMBL1818702

SCHEMBL1818702

[CH2]COC(=O)c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.55
ALDH1A1 P00352 7/20 0.55
KDM4E B2RXH2 1/20 0.55
GAA P10253 1/20 0.55
NPSR1 Q6W5P4 2/20 0.54
PKM P14618 1/20 0.54
CES2 O00748 1/20 0.53
CES1 P23141 1/20 0.53
LMNA P02545 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
P4HTM Q9NXG6 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
APP P05067 1/20 0.51
NPC1 O15118 1/20 0.51
THRB P10828 1/20 0.51
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
AGTR1 P30556 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4196770 0.86 APP (0.56) L3MBTL1ALDH1A1KDM4EGAANPSR1
SCHEMBL27221774 0.85 L3MBTL1 (0.58) L3MBTL1ALDH1A1KDM4EGAANPSR1
SCHEMBL1503221 0.83 L3MBTL1 (0.56) L3MBTL1ALDH1A1KDM4EGAANPSR1
SCHEMBL30099767 0.83 L3MBTL1 (0.60) L3MBTL1ALDH1A1KDM4EGAANPSR1
SCHEMBL17205087 0.81 L3MBTL1 (0.55) L3MBTL1ALDH1A1KDM4EGAANPSR1
Ethyl Picolinate SCHEMBL126181 0.81 CYP1A2 (0.65) L3MBTL1ALDH1A1KDM4EGAANPSR1
SCHEMBL29554609 0.81 L3MBTL1 (0.55) L3MBTL1ALDH1A1KDM4EGAANPSR1
Ethyl Picolinate SCHEMBL30016787 0.81 CYP1A2 (0.65) L3MBTL1ALDH1A1KDM4EGAANPSR1
SCHEMBL2149142 0.81 NPSR1 (0.57) L3MBTL1ALDH1A1KDM4EGAANPSR1
Ethyl Picolinate SCHEMBL8661716 0.81 CYP1A2 (0.65) L3MBTL1ALDH1A1KDM4EGAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024080351-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2024-04-18 WO disclosed
WO-2024058164-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2024-03-21 WO disclosed
WO-2023136269-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-07-20 WO disclosed
WO-2023085390-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-05-19 WO disclosed
US-20210371664-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT NISSAN CHEMICAL CORPORATION (JP) 2021-12-02 US disclosed
US-11111387-B2 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2021-09-07 US disclosed
WO-2020145175-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2020-07-16 WO disclosed
US-20180244922-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-08-30 US disclosed
EP-2499120-A1 NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS Novadex Pharmaceuticals AB (SE) 2012-09-19 EP disclosed
WO-2011056126-A1 NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS NOVADEX PHARMACEUTICALS AB (SE) 2011-05-12 WO disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed